Skip to main content
$2.60 -$0.10 (-3.7%)

01:02 PM EST on 12/02/20

Acer Therapeutics Inc (NASDAQ:ACER)

CAPS Rating: 1 out of 5

A biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease.

Current Price $2.60 Mkt Cap $33.2M
Open $2.70 P/E Ratio 0.00
Prev. Close $2.70 Div. (Yield) $0.00 (0.0%)
Daily Range $2.60 - $2.74 Volume 38,298
52-Wk Range $1.08 - $7.25 Avg. Daily Vol. 74,166

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

34 Outperform
18 Underperform
 

All-Star Players

3 Outperform
9 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ACER Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

whoodatstockhot (85.65)
Submitted August 07, 2013

Cutting edge research being completed at Opexa, huge buyout potential here, one of those specs that could change how MS is treated. Balance sheet strong, low risk of secondary. Great risk reward, with over 500% upisde quite possible for long-term… More

jed71 (93.48)
Submitted November 07, 2016

Well, this certainly seems to shed light on some of their problems: "Opexa Therapeutics reduces workforce by 40% in light of the negative Phase 2b Abili-T clinical trial top-line results announced on October 28""Following further analysis of the… More

Recent Community Commentary

Read the most recent pitches from players about ACER.

Recs

0
Member Avatar allstar31 (99.94) Submitted: 9/12/2014 11:14:52 PM : Underperform Start Price: $111.01 NASDAQ:ACER Score: +181.51

Uses known stock pump and dumper Redchip.com for PR purposes. Garbage.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/15/2013 3:00:17 PM : Outperform Start Price: $189.70 NASDAQ:ACER Score: -202.26

One massive IHS on monhtly

Recs

1
Member Avatar whoodatstockhot (85.65) Submitted: 8/7/2013 1:07:06 PM : Outperform Start Price: $247.69 NASDAQ:ACER Score: -215.36

Cutting edge research being completed at Opexa, huge buyout potential here, one of those specs that could change how MS is treated. Balance sheet strong, low risk of secondary. Great risk reward, with over 500% upisde quite possible for long-term holders in 2014.

Leaderboard

Find the members with the highest scoring picks in ACER.

Score Leader

whatsthepoint

whatsthepoint (99.97) Score: +452.36

The Score Leader is the player with the highest score across all their picks in ACER.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
MaxPwr273 70.12 10/26/2011 Underperform 5Y $364.50 -99.28% +193.77% +293.05 0 Comment
2011Fool 92.20 2/18/2011 Underperform NS $632.90 -99.59% +172.52% +272.10 0 Comment
Halffrenzy 24.72 3/13/2013 Underperform 5Y $178.11 -98.53% +135.09% +233.62 0 Comment
saab93boi < 20 3/26/2013 Underperform 3W $211.24 -98.76% +134.63% +233.39 0 Comment
Mary953 88.70 3/25/2013 4/6/2018 Underperform 5Y $173.14 -98.49% +134.72% +233.21 0 Comment
stockjock11 22.49 5/22/2013 Underperform 5Y $138.34 -98.11% +117.29% +215.40 0 Comment
allstar31 99.94 9/15/2014 Underperform 5Y $111.01 -97.64% +83.86% +181.51 1 Comment
zzlangerhans 97.61 10/31/2016 Underperform 1Y $8.80 -70.29% +72.27% +142.56 0 Comment
tsperbeck 97.59 2/3/2017 Underperform 5Y $10.44 -74.94% +59.70% +134.64 0 Comment
johnnyrocku 99.91 10/16/2017 Underperform 5Y $18.69 -86.00% +43.60% +129.60 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ACER.